241 related articles for article (PubMed ID: 11376123)
1. IGF-I receptor signalling in transformation and differentiation.
Valentinis B; Baserga R
Mol Pathol; 2001 Jun; 54(3):133-7. PubMed ID: 11376123
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
3. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
4. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
5. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
Mur C; Arribas M; Benito M; Valverde AM
Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
[TBL] [Abstract][Full Text] [Related]
7. ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation.
Morrison KB; Tognon CE; Garnett MJ; Deal C; Sorensen PH
Oncogene; 2002 Aug; 21(37):5684-95. PubMed ID: 12173038
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.
Byron SA; Horwitz KB; Richer JK; Lange CA; Zhang X; Yee D
Br J Cancer; 2006 Nov; 95(9):1220-8. PubMed ID: 17043687
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor I receptor activity in human medulloblastomas.
Del Valle L; Enam S; Lassak A; Wang JY; Croul S; Khalili K; Reiss K
Clin Cancer Res; 2002 Jun; 8(6):1822-30. PubMed ID: 12060623
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
11. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
Sun H; Baserga R
Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443
[TBL] [Abstract][Full Text] [Related]
12. Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein.
Kim EJ; Shin HK; Park JH
J Med Food; 2005; 8(4):431-8. PubMed ID: 16379552
[TBL] [Abstract][Full Text] [Related]
13. Function of the IGF-I receptor in breast cancer.
Surmacz E
J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):95-105. PubMed ID: 10791772
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to apoptosis in insulin-like growth factor-I receptor-deficient brown adipocytes.
Valverde AM; Mur C; Brownlee M; Benito M
Mol Biol Cell; 2004 Nov; 15(11):5101-17. PubMed ID: 15356271
[TBL] [Abstract][Full Text] [Related]
15. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
16. Insulin and IGF-I receptors signaling in protection from apoptosis.
Prisco M; Romano G; Peruzzi F; Valentinis B; Baserga R
Horm Metab Res; 1999; 31(2-3):80-9. PubMed ID: 10226786
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I regulates proliferation and osteoblastic differentiation of calcifying vascular cells via extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase pathways.
Radcliff K; Tang TB; Lim J; Zhang Z; Abedin M; Demer LL; Tintut Y
Circ Res; 2005 Mar; 96(4):398-400. PubMed ID: 15692088
[TBL] [Abstract][Full Text] [Related]
18. Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas.
Wang JY; Del Valle L; Gordon J; Rubini M; Romano G; Croul S; Peruzzi F; Khalili K; Reiss K
Oncogene; 2001 Jun; 20(29):3857-68. PubMed ID: 11439349
[TBL] [Abstract][Full Text] [Related]
19. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
[TBL] [Abstract][Full Text] [Related]
20. Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling.
DeAngelis T; Chen J; Wu A; Prisco M; Baserga R
Oncogene; 2006 Jan; 25(1):32-42. PubMed ID: 16170362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
